Eplontersen

Wainua

45 MG / 0.8 ML SolutionCanadaMarketedAuthorised 7 Oct 2024

In other countries

The same active substances on other registers, the same brand first.

WainuaBrazil · Astrazeneca do Brasil LtdaSame brand
Wainua Solution for Injection in Autoinjector 45MG/0.8MLSingapore · 45mg/0.8ml · injection, solution · Astrazeneca Singapore Pte LTDSame brand
WainuaUnited States · 45MG BASE/0.8ML · solution · Astrazeneca ABSame brand
Wainua (Autoinjector)United States · 45MG BASE/0.8ML · solution · Astrazeneca ABSame brand
Wainzua 45 MG Solucion Inyectable en Pluma PrecargadaSpain · 47 mg · solución inyectable en pluma precargada · Astrazeneca AbSame substance
WainzuaEuropean Union · AstraZeneca ABSame substance
WainzuaCroatiaSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Eplontersen

Wainua

45 MG / 0.8 ML SolutionCanadaMarketedAuthorised 7 Oct 2024

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

WainzuaItaly · Soluzione iniettabile in penna pre-riempita · Astrazeneca AB

Wainzua 45 mg oplossing voor injectie in een voorgevulde penNetherlands · Oplossing voor injectie · AstraZeneca AB

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Eplontersen
Strength: 45 MG / 0.8 ML
Dosage form: Solution
Route: Subcutaneous
Register: Canada (Health Canada)
Status: Marketed
Authorised: 7 Oct 2024
Registration: DIN 02548909
Marketing authorisation holder: Astrazeneca Canada INC
ATC code: N07XX21
Group: Nervous system
Supply: PRESCRIPTION